Beijing Beilu Pharmaceutical (300016.SZ) obtained the drug registration certificate for Bimatoprost Eye Drops.

17:15 20/09/2026

Beijing Beilu Pharmaceutical (300016.SZ) announced that the company recently received the Drug Registration Certificate for Bimatoprost Eye Drops approved and issued by the National Medical Products Administration. The originator of Bimatoprost Eye Drops is Allergan of the United States, and the product is used to reduce intraocular pressure in patients with open-angle glaucoma and ocular hypertension. Bimatoprost Eye Drops was approved under Category 4 of chemical drugs and is deemed to have passed the consistency evaluation of the quality and efficacy of generic drugs, further enriching the company's formulation product pipeline and achieving product layout in the ophthalmology field.

Beijing Beilu Pharmaceutical (300016.SZ) announced that the company recently received the Drug Registration Certificate for Bimatoprost Eye Drops approved and issued by the National Medical Products Administration. The originator of Bimatoprost Eye Drops is Allergan, Inc. of the United States, and it is used to reduce intraocular pressure in patients with open-angle glaucoma and ocular hypertension. Bimatoprost Eye Drops was approved under Category 4 of chemical drugs, and is deemed to have passed the consistency evaluation of generic drug quality and efficacy, further enriching the company's formulation product pipeline and achieving product layout in the ophthalmology field.

Beijing Huayuan Xinhang Holding (600743.SH)'s controlling shareholder is proposed to be changed to Financial Street Holdings Capital.

Shenzhen Techwinsemi Technology (001309.SZ)'s application for additional stock issuance has been approved by the Listing Review Center of the Shenzhen Stock Exchange.

Anhui Honglu Steel Construction (002541.SZ) subsidiary signs major business contract, with an estimated contract value of approximately 280 million yuan.

Beijing Huayuan Xinhang Holding (600743.SH)'s controlling shareholder is proposed to be changed to Financial Street Holdings Capital.

Shenzhen Techwinsemi Technology (001309.SZ)'s application for additional stock issuance has been approved by the Listing Review Center of the Shenzhen Stock Exchange.

Anhui Honglu Steel Construction (002541.SZ) subsidiary signs major business contract, with an estimated contract value of approximately 280 million yuan.